CALR and neoplasm: CRT, an endoplasmic reticulum-associated molecular chaperone, can also block the CD47 receptor on tumor cells, thereby reducing the “don't eat me” signals generated by macrophages and DCs in response to CD47 binding, and attenuating immune evasion by tumor cells [85].